Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
暂无分享,去创建一个
Rui Chen | Tao Wang | Lei Wang | Lin-Tao Jia | Rui Zhang | R. Chen | Tao Wang | A. Yang | Lei Wang | L. Jia | Rui Zhang | L. Yao | Weihong Wen | Jing Zhao | J. Zhao | Zhang-Yan Guo | Bo Xin | Weihong Wen | Libo Yao | An-Gang Yang | Zhang-Yan Guo | Bo Xin
[1] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[2] D. Pei. Regulation of Pluripotency and Reprogramming by Transcription Factors* , 2009, Journal of Biological Chemistry.
[3] P. Pandolfi,et al. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.
[4] H. Schöler,et al. Absence of OCT4 Expression in Somatic Tumor Cell Lines , 2008, Stem cells.
[5] N. Wong,et al. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. , 2003, Journal of hepatology.
[6] Y. Bergman,et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.
[7] G. Chirn,et al. Multiple Retropseudogenes from Pluripotent Cell-specific Gene Expression Indicates a Potential Signature for Novel Gene Identification* , 2005, Journal of Biological Chemistry.
[8] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[9] E. Punch,et al. Pseudogenes: pseudo-functional or key regulators in health and disease? , 2011, RNA.
[10] A. Hao,et al. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma , 2011, The Journal of pathology.
[11] N. Wong,et al. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. , 2012, Carcinogenesis.
[12] S. Dhanasekaran,et al. Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers , 2012, Cell.
[13] Jingjing Liu,et al. MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 , 2012, PloS one.
[14] Beth Israel,et al. Decision letter: Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010 .
[15] T. Mueller,et al. Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells , 2009, Cellular and Molecular Life Sciences.
[16] P. Andrews,et al. Specific Knockdown of Oct4 and β2‐microglobulin Expression by RNA Interference in Human Embryonic Stem Cells and Embryonic Carcinoma Cells , 2004, Stem cells.
[17] X. Wang,et al. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. , 2012, Seminars in oncology.
[18] C. Croce,et al. MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.
[19] R. Montironi,et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia , 2007, The Journal of pathology.
[20] D. Steinemann,et al. Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions , 2008, Modern Pathology.
[21] C. Holding,et al. Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.
[22] Yi Shen,et al. Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. , 2012, Frontiers in bioscience.
[23] S. Gitelman,et al. Abundant adrenal-specific transcription of the human P450c21A "pseudogene". , 1993, The Journal of biological chemistry.
[24] G. McCaughan,et al. Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin‐6 signaling , 2008, Hepatology.
[25] Frank J. Sørensen,et al. Diagnostic and prognostic microRNAs in stage II colon cancer. , 2008, Cancer research.
[26] A. Jemal,et al. Global Cancer Statistics , 2011 .
[27] Oliver H. Tam,et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes , 2008, Nature.
[28] H. Schöler,et al. The molecular biology of Oct-4 in the early mouse embryo. , 1998, Molecular human reproduction.
[29] A. Iwama,et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. , 2007, Gastroenterology.
[30] S. Byers,et al. Liver stem cells and hepatocellular carcinoma , 2009, Hepatology.
[31] P. Lu,et al. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway , 2010, Hepatology.
[32] Hong-Yang Wang,et al. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. , 2012, Gastroenterology.
[33] F. Wang,et al. Octamer 4 Small Interfering RNA Results in Cancer Stem Cell-Like Cell Apoptosis , 2012 .
[34] Yvonne Tay,et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation , 2009, Nature.
[35] S. Qiu,et al. Coexpression of Stemness Factors Oct4 and Nanog Predict Liver Resection , 2012, Annals of Surgical Oncology.
[36] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[37] Y. Atlasi,et al. OCT‐4, an embryonic stem cell marker, is highly expressed in bladder cancer , 2007, International journal of cancer.
[38] Peter Schirmacher,et al. MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.
[39] J. Miyazaki,et al. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.
[40] P. Brown,et al. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma , 2012, Nature Reviews Gastroenterology &Hepatology.
[41] M. Todesco,et al. Target mimicry provides a new mechanism for regulation of microRNA activity , 2007, Nature Genetics.
[42] P. Lu,et al. Octamer 4 ( Oct 4 ) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct 4 – AKT – ATP-Binding Cassette G 2 Pathway , 2010 .
[43] J. Lou,et al. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. , 2012, Oncology reports.
[44] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[45] Jin Han,et al. Oct4 pseudogenes are transcribed in cancers. , 2005, Biochemical and biophysical research communications.
[46] E. Lai,et al. The long and short of inverted repeat genes in animals: MicroRNAs, mirtrons and hairpin RNAs , 2008, Cell cycle.
[47] P. Gimotty,et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation , 2012, Oncogene.
[48] H. Schöler,et al. Stem cell pluripotency and transcription factor Oct4 , 2002, Cell Research.
[49] G. Pan,et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.
[50] A. Clark,et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma , 2005, Cancer.
[51] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.